Skip to main content
. 2010 Nov 4;66A(3):279–286. doi: 10.1093/gerona/glq190

Table 3.

Comparative Results of the Full Versus Truncated Analyzes From Each Data set and Their Implications for the Comparative Direct Costs of 2-Y Versus Full Life-Span Study*

Study Treatment Group N β2y βfull Difference p Value Variance Ratio Cost Ratio
1 A 45 −1.249 –0.614 0.6352 .055 3.1 3.9
1 B 45 −0.644 0.008 0.6523 .006 2.2
1 C 45 −1.386 –0.308 1.0776 .002 3.4
1 D 45 1.589 2.083 0.4937 .001 1.2
1 E 45 −0.872 –0.444 0.4286 .123 2.5
1 F 45 −0.742 –0.327 0.4151 .139 2.4
1 G 45 −0.927 –0.323 0.6039 .064 2.6
2 A 41 −0.968 –0.759 0.2086 .168 1.6 4.0
2 B 39 −0.437 –0.720 –0.2830 .027 1.2
2 C 49 −0.405 –0.540 –0.1346 .217 1.3
2 D 48 −0.303 –0.441 –0.1377 .192 1.3
3 A 16 0.797 0.756 –0.0406 .693 1.2 1.8
4 A 98 −0.205 –0.039 0.1660 .506 3.4 3.7
4 B 99 −0.111 0.020 0.1302 .557 3.3
4 C 99 0.289 0.171 –0.1179 .459 2.7
4 D 99 −0.311 0.084 0.3954 .090 3.6
4 E 97 0.249 0.073 –0.1764 .332 2.7
5 A 60 −0.866 –0.160 0.7054 .008 2.9 2.9
5 B 60 −0.030 –0.047 –0.0174 .873 2.0
6 A 298 0.003 –0.030 –0.0334 .671 3.0 4.0
6 B 308 −0.310 –0.070 0.2402 .043 3.6
6 C 308 −0.385 –0.218 0.1678 .135 3.8
6 D 308 −0.189 –0.002 0.1874 .096 3.4
7 A 206 −0.063 0.286 0.3485 .114 5.9 3.6
7 B 57 0.308 0.241 –0.0667 .747 4.7
7 C 51 0.518 0.106 –0.4127 .114 4.0
8 A 47 −1.307 –2.148 –0.8414 .646 2.3 2.6
8 B 28 −0.778 –1.141 –0.3624 .905 2.2
8 C 35 −1.711 –2.233 –0.5214 .398 7.0
8 D 38 0.256 0.088 –0.1675 .129 6.5
8 E 32 0.524 0.481 –0.0427 .450 5.9
9 A 60 −0.187 –0.240 –0.0535 .947 4.2 3.9
9 B 55 −0.224 –0.160 0.0641 .848 4.2
9 C 54 −0.605 –0.300 0.3046 .586 5.3
9 D 55 −0.599 –0.510 0.0888 .878 5.3
9 E 55 −1.369 –0.790 0.5792 .547 8.4
9 F 55 −0.851 –0.510 0.3412 .576 5.9
9 G 55 0.997 0.590 –0.4068 .317 3.0
9 H 55 −0.016 –0.100 –0.0839 .878 4.2
10 A 44 −0.512 0.027 0.5385 .507 11.6 1.8
10 B 45 0.185 –0.251 –0.4365 .585 7.9
11 A 51 −0.041 –0.144 –0.1035 .927 24.0 2.1
12 A 57 −0.996 –1.150 –0.1535 .696 6.4 2.4
12 B 60 −2.696 –3.719 –1.0236 .317 12.6
12 C 71 −2.168 –3.212 –1.0444 .165 7.7
13 A 74 −0.221 –0.897 –0.6759 .137 7.1 2.3
14 A 67 −1.818 –0.773 1.0450 .447 34.0 2.1
15 A 53 −2.161 –2.055 0.1059 .916 4.4 2.8
15 B 51 −0.521 –0.713 –0.1922 .848 2.2

Note: *Some studies had more than two groups, which yields more than one estimated treatment effect. We have denoted each comparison within a study as A, B, etc.